These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
135 related items for PubMed ID: 25391709
1. Drug holiday utilisation in ADHD-diagnosed children and adolescents in South Africa. Regnart J, McCartney J, Truter I. J Child Adolesc Ment Health; 2014; 26(2):95-107. PubMed ID: 25391709 [Abstract] [Full Text] [Related]
2. Drug Holidays From ADHD Medication: International Experience Over the Past Four Decades. Ibrahim K, Donyai P. J Atten Disord; 2015 Jul; 19(7):551-68. PubMed ID: 25253684 [Abstract] [Full Text] [Related]
3. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study. Quintana H, Cherlin EA, Duesenberg DA, Bangs ME, Ramsey JL, Feldman PD, Allen AJ, Kelsey DK. Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731 [Abstract] [Full Text] [Related]
4. What stops practitioners discussing medication breaks in children and adolescents with ADHD? Identifying barriers through theory-driven qualitative research. Ibrahim K, Donyai P. Atten Defic Hyperact Disord; 2018 Dec; 10(4):273-283. PubMed ID: 29982921 [Abstract] [Full Text] [Related]
5. Overlapping Prescriptions of Stimulants for Children and Adolescents With Attention-Deficit Hyperactivity Disorder. Chen CY, Yeh HH, Fang SY, Wu EC, Chang IS, Lin KM. Psychiatr Serv; 2012 Oct; 63(10):1011-8. PubMed ID: 22911441 [Abstract] [Full Text] [Related]
6. Review of medication adherence in children and adults with ADHD. Adler LD, Nierenberg AA. Postgrad Med; 2010 Jan; 122(1):184-91. PubMed ID: 20107302 [Abstract] [Full Text] [Related]
7. Prevalence of methylphenidate prescription among school-aged children in a Swiss population: increase in the number of prescriptions in the Swiss Canton of Vaud, from 2002 to 2005, and changes in patient demographics. Gumy C, Huissoud T, Dubois-Arber F. J Atten Disord; 2010 Nov; 14(3):267-72. PubMed ID: 20484708 [Abstract] [Full Text] [Related]
8. Methylphenidate: prescribing patterns in a South African primary care patient population. Truter I. J Clin Pharm Ther; 2005 Feb; 30(1):59-63. PubMed ID: 15659004 [Abstract] [Full Text] [Related]
9. [Central stimulants in the treatment of children with ADHD: unknown long-term effect and uncertain pharmacological documentation]. Zetterström R. Lakartidningen; 2002 Feb 14; 99(7):677-80. PubMed ID: 11887717 [No Abstract] [Full Text] [Related]
10. Methylphenidate use for attention deficit hyperactivity disorder in northern Israel--a controversial issue. Fogelman Y, Kahan E. Isr Med Assoc J; 2001 Dec 14; 3(12):925-7. PubMed ID: 11794916 [Abstract] [Full Text] [Related]
11. [Sociodemographic and clinical factors associated with compliance to methylphenidate treatment in children with attention deficit hyperactivity disorder]. Kiliç BG, Bilgiç A, Gürkan K, Aysev A. Turk Psikiyatri Derg; 2007 Dec 14; 18(3):207-13. PubMed ID: 17853975 [Abstract] [Full Text] [Related]
12. Quality of life of methylphenidate treatment-responsive adolescents with attention-deficit/hyperactivity disorder. Yang PC, Lung FW, Chiou SS, Yen CF, Fuh JL. Kaohsiung J Med Sci; 2012 May 14; 28(5):279-84. PubMed ID: 22531308 [Abstract] [Full Text] [Related]
13. Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample. Yang P, Hsu HY, Chiou SS, Chao MC. Aust N Z J Psychiatry; 2007 Dec 14; 41(12):998-1004. PubMed ID: 17999272 [Abstract] [Full Text] [Related]
14. [Methylphenidate and sleep: Results of a multicentre study on a population of children with attention deficit hyperactivity disorder]. Tomás Vila M, Aleu Pérez-Gramunt M, Beseler Soto B, Benac Prefasi M, Pantoja Martínez J, Pitarch Castellano I. An Pediatr (Barc); 2010 Aug 14; 73(2):78-83. PubMed ID: 20605120 [Abstract] [Full Text] [Related]
15. Prescribing methylphenidate for moderate ADHD. McClure I. BMJ; 2013 Oct 16; 347():f6216. PubMed ID: 24133145 [No Abstract] [Full Text] [Related]
16. Buspirone versus methylphenidate in the treatment of children with attention- deficit/ hyperactivity disorder: randomized double-blind study. Mohammadi MR, Hafezi P, Galeiha A, Hajiaghaee R, Akhondzadeh S. Acta Med Iran; 2012 Oct 16; 50(11):723-8. PubMed ID: 23292622 [Abstract] [Full Text] [Related]
17. Prescriptions for ADHD medication, 2004-08. Lillemoen PK, Kjosavik SR, Hunskår S, Ruths S. Tidsskr Nor Laegeforen; 2012 Sep 04; 132(16):1856-60. PubMed ID: 22986969 [Abstract] [Full Text] [Related]
18. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit]. Bricard C, Boidein F. Encephale; 2001 Sep 04; 27(5):435-43. PubMed ID: 11760693 [Abstract] [Full Text] [Related]
19. Influence of methylphenidate on spatial attention asymmetry in adolescents with attention deficit hyperactivity disorder (ADHD): preliminary findings. Silk TJ, Newman DP, Eramudugolla R, Vance A, Bellgrove MA. Neuropsychologia; 2014 Apr 04; 56():178-83. PubMed ID: 24486422 [Abstract] [Full Text] [Related]
20. Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in children. Swanson J, Gupta S, Guinta D, Flynn D, Agler D, Lerner M, Williams L, Shoulson I, Wigal S. Clin Pharmacol Ther; 1999 Sep 04; 66(3):295-305. PubMed ID: 10511066 [Abstract] [Full Text] [Related] Page: [Next] [New Search]